In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?

MLA

Jihae An, et al. “In Prostatic Transition Zone Lesions (PI-RADS v2.1): Which Subgroup Should Be Biopsied?” The Egyptian Journal of Radiology and Nuclear Medicine, vol. 52, no. 1, Aug. 2021, pp. 1–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e031c7c701b17e974faee4dcbaedd1f9&authtype=sso&custid=ns315887.

APA

Jihae An, Dong Hyun Oh, Jae Young Seo, Mu-Sik Lee, Young Joong Kim, Cheol Mog Hwang, & Keum Won Kim. (2021). In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied? The Egyptian Journal of Radiology and Nuclear Medicine, 52(1), 1–11.

Chicago

Jihae An, Dong Hyun Oh, Jae Young Seo, Mu-Sik Lee, Young Joong Kim, Cheol Mog Hwang, and Keum Won Kim. 2021. “In Prostatic Transition Zone Lesions (PI-RADS v2.1): Which Subgroup Should Be Biopsied?” The Egyptian Journal of Radiology and Nuclear Medicine 52 (1): 1–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e031c7c701b17e974faee4dcbaedd1f9&authtype=sso&custid=ns315887.